Medicines and Healthcare Products Regulatory Agency approves the usage of the Moderna COVID-19 vaccine for children between the ages of 12 and 17
The Medicines and Healthcare Products Regulatory Agency approves the usage of the Moderna COVID-19 vaccine for children between the ages of 12 and 17, becoming the second vaccine to be approved for use in children after the Pfizer-BioNTech vaccine.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthMedicines and Healthcare Products Regulatory Agency approves the usage of the Moderna COVID-19 vaccine for children between the ages of 12 and 17
View Premium plansBrowse free archive reportsThe Medicines and Healthcare Products Regulatory Agency approves the usage of the Moderna COVID-19 vaccine for children between the ages of 12 and 17, becoming the second vaccine to be approved for use in children after the Pfizer-BioNTech vaccine.